On August 30, 2016 the Administrator of the Drug Enforcement Administration (DEA) issued a notice of intent to schedule the opioids mitragynine and 7-hydroxymitragynine, which are the main active constituents of the plant Kratom, into the schedule l category. The agency stated this action is based on…